Board of Directors
365体育足球比分The Board of Origin consists of a non-executive chairman, three executive directors and four non-executive directors.
Tom O'Mahony (57)
Chief Executive Officer
Tom O'Mahony was appointed to the Origin Board on 9 February 2007. Tom is CEO of Origin since its formation in 2006. Prior to his appointment he was Chief Operations Officer of IAWS Group plc having previously held a number of senior management positions at IAWS, spanning functional areas including corporate development, business integration and financial control within the Group.
Declan Giblin (63)
365体育足球比分Declan Giblin was appointed to the Origin Board on 15 October 2008. Declan is Head of Corporate Development. He was formerly Chief Executive of Masstock and has been the driving force behind the development of Agrii over a 20-year period.
Sean Coyle (47)
Sean Coyle joined Origin in September 2018 as Chief Financial Officer and was appointed to the Origin Board in October 2018. Sean was previously Group Finance Director of UDG Healthcare plc and also served as Managing Director of UDG’s Healthcare Supply Chain Division. Prior to UDG, Sean was Chief Financial Officer and an Executive Director of Aer Lingus plc. He also spent over ten years at Ryanair Holdings plc where he held a number of senior management positions. Sean is a fellow of the Institute of Chartered Accountants in Ireland having trained with KPMG in Dublin.
Rose Hynes (62)
365体育足球比分Rose Hynes was appointed to the Origin Board on 1 October 2015. Rose is Chairman of Shannon Group plc and Non-Executive Director of Total Produce plc, IPL Plastic Inc. and Eircom Holdings (Ireland) Ltd She previously held a number of senior Executive positions with GPA Group plc in the period 1988-2002 including General Counsel and Head of the Commercial Department. A law graduate of University College Dublin and a lawyer, Rose is an Associate of the Irish Institute of Taxation and of the Chartered Institute of Arbitrators.
Chair: Nomination and Corporate Governance Committee
Member: Remuneration Committee
Kate Allum (54)
Kate Allum was appointed to the Origin Board on 1 October 2015. Kate is Chief Executive Officer of CeDo Limited. She is also a Non-Executive Director of Cranswick plc where she is a member of the Audit, Remuneration and Nomination Committees. Kate previously held a number of senior management positions in the food and agricultural sector, including Chief Executive of First Milk Limited and Head of European Supply Chain for McDonald’s Restaurants.
Chair: Remuneration Committee
Member: Audit and Risk Committee
Gary Britton (65)
365体育足球比分Gary Britton was appointed to the Origin Board on 1 October 2015. Gary is a Non-Executive Director of Cairn Homes plc and The Cheshire Foundation in Ireland. He was previously a partner in KPMG where he served in a number of senior positions, including the firm’s Board, the Remuneration and Risk Committees and as head of its Audit Practice. Gary is a member of the Institute of Chartered Accountants in Ireland, the Institute of Directors and the Institute of Banking. He is also a Certified Bank Director as designated by the Institute of Banking.
Chair:365体育足球比分 Audit and Risk Committee
Member: Nomination and Corporate Governance Committee
Hugh McCutcheon (65)
Non-Executive Senior Independent Director
Hugh McCutcheon was appointed to the Origin Board on 21 November 2011. Hugh is Non-Executive Director of IPL Plastics Inc. He is also an Alternate Director at the Irish Takeover Panel. He was formerly Head of Corporate Finance at Davy. Hugh is a fellow of the Institute of Chartered Accountants in Ireland, having trained with PWC.
Member:365体育足球比分 Nomination and Corporate Governance Committee, Audit and Risk Committee
Christopher Richards (66)
365体育足球比分Christopher Richards was appointed to the Origin Board on 1 October 2015. Chris is Chief Executive Officer of Plant Health Care plc and Non-Executive Chairman of Nanoco Group plc as well as Non-Executive Director of Volac International Limited. He has more than 30 years international experience in the agriculture industry and currently farms in the West of England. Chris previously spent 20 years in various leadership roles with Syngenta and its predecessor companies before serving as CEO and, later, Non-Executive Chairman of Arysta LifeScience. Chris holds an MA in Zoology and a D. Phil. in Ecology from Oxford University.
Member: Remuneration Committee